Sterile Compounding Pharmacy Security Risk Assessment: A Complete Guide and Checklist

A Sterile Compounding Pharmacy Security Risk Assessment helps you protect patients, people, and products by systematically finding and fixing vulnerabilities across facilities, workflows, and data. This complete guide and checklist shows you how to evaluate risks, align with USP 797 and 800, deploy Assessment of Risk tools, strengthen security controls, monitor cleanrooms, document compliance, and audit performance.

Use it to address active pharmaceutical ingredients risk, hazardous drug handling, sterile compounding facility design, engineering controls, environmental monitoring, personnel protective equipment, and regulatory compliance documentation without adding unnecessary complexity.

Sterile Compounding Risk Evaluation

Define scope, assets, and threats

• Assets: sterile products, active pharmaceutical ingredients (APIs), controlled substances, equipment, cleanrooms, data, and personnel.
• Threats: microbial contamination, cross-contamination, product tampering, theft/diversion, supply chain adulteration, data loss, cyber intrusion, utility failures, and process errors.
• Exposure points: receiving, storage, compounding, labeling, quarantine, release, transport, waste, and recordkeeping.

Risk scoring method

Use a consistent rubric to score severity, likelihood, and detectability; multiply or weight scores to generate a risk priority number. Rank risks and set action thresholds so you can triage remediation work and track residual risk after controls are applied.

Targeted considerations

• Active pharmaceutical ingredients risk: verify source, potency, identity, chain-of-custody, storage conditions, access control, and reconciliation of high-value or high-potency APIs.
• Hazardous drug handling: assess exposure potential during receiving, compounding, transport, and waste; ensure containment and PPE are appropriate for manipulation complexity.
• Sterile compounding facility design: confirm room classification, pressure cascades, pass-throughs, and materials flow minimize contamination and unauthorized access.

Risk evaluation checklist

• Map end-to-end process with swimlanes and handoffs.
• Identify failure modes for each step (contamination, mix-ups, mislabeling, diversion, data issues).
• List existing controls (engineering, administrative, PPE, monitoring, digital).
• Score inherent risk, then residual risk after controls.
• Assign owners, mitigation actions, and deadlines; add to the risk register.
• Set review cadence tied to incidents, changes, and audit results.

USP 797 and 800 Compliance Requirements

USP 797 essentials for sterile compounding

• Personnel: hand hygiene, garbing, aseptic technique training, media fills, and gloved fingertip/thumb sampling with ongoing competency.
• Facilities: ISO-classified primary engineering controls within compliant buffer and ante areas; pressure differentials and air changes maintained and logged.
• Operations: validated cleaning/disinfection, beyond-use dating practices, labeling, batch documentation, and segregation to prevent cross-contamination.
• Quality: certification of primary and secondary engineering controls, environmental monitoring, and investigation/CAPA for excursions.

USP 800 essentials for hazardous drug handling

• Inventory: create and maintain an HD list; define receiving, storage, compounding, dispensing, and transport practices.
• Containment: use appropriate engineering controls (C-PEC within C-SEC), negative pressure where required, and externally vented systems as applicable.
• PPE: ensure personnel protective equipment selection and donning/doffing match manipulation risk; include spill kits and decontamination materials.
• Deactivation/decontamination/cleaning: standardize agents, frequencies, and verification methods.
• Medical surveillance and spill response: establish programs and training with documented drills.

Integrating 797 and 800

For sterile HD compounding, comply with both chapters—apply USP 797 aseptic and environmental expectations and layer USP 800 containment, PPE, and handling controls. Document the rationale for every decision in regulatory compliance documentation and keep it inspection-ready.

Implementation of Assessment of Risk Tools

Purpose and when to use

Assessment of Risk (AoR) tools structure how you evaluate HD characteristics, manipulation complexity, exposure potential, and feasible controls. Use them to justify controls for specific tasks and substances, especially when handling certain dosage forms where alternative strategies may be acceptable.

Core AoR elements

• Substance profile: name, dosage form, concentration, volatility, antineoplastic status, and active pharmaceutical ingredients risk factors.
• Process profile: steps performed, frequency, duration, volume, and equipment used.
• Exposure assessment: routes (inhalation, dermal, ingestion), likelihood, and severity.
• Controls mapping: engineering controls, administrative controls, personnel protective equipment, and environmental monitoring requirements.
• Approval and periodic review: sign-offs by leadership and quality; update after incidents or changes.

AoR implementation checklist

• Adopt a standard template and scoring rubric aligned with USP 800 intent.
• Train staff to complete AoRs consistently and cite supporting procedures.
• Store approved AoRs with traceability to SOPs, training, and batch records.
• Set review triggers (annual, process change, equipment change, excursion, or audit finding).

Pharmacy Security Controls Analysis

Physical and process controls

• Access control: restrict entry to cleanrooms, HD rooms, and API storage with badges and logs; prevent tailgating and maintain visitor escorts.
• Surveillance and tamper evidence: camera coverage of critical areas; tamper-evident seals for kits, carts, and shippers; seal reconciliation.
• Chain-of-custody: barcode or serialized tracking from receipt to release; two-person verification for high-risk steps and for wasting.
• Inventory security: segregated, locked storage for APIs and controlled substances; daily counts and discrepancy investigations.
• Receiving and shipping: inspect for damage/tampering; quarantine suspect items; use validated, secure transport with temperature control as needed.

Engineering and digital controls

• Engineering controls: certified PECs/SECs, interlocked doors, pressure alarms, pass-throughs with interlocks, and backup power for critical systems.
• Digital safeguards: role-based access to compounding software, audit trails, multi-factor authentication, timely patching, and validated label workflows.
• Resilience: downtime procedures, data backups, generator testing, and incident response plans that include contamination, diversion, and cyber events.

Security control maturity check

• Ad-hoc: undocumented practices; reactive fixes.
• Defined: approved SOPs and baseline training.
• Managed: monitoring, metrics, and periodic testing.
• Optimized: risk-based improvements and automation tied to leading indicators.

Cleanroom Compliance and Monitoring

Environmental monitoring program

• Air: nonviable particle counts and viable air sampling at defined frequencies in ISO 5, 7, and 8 areas with alert/action levels.
• Surfaces: routine surface sampling of PEC interiors, worktables, pass-throughs, and high-touch points after cleaning but before compounding.
• Trend analysis: chart results by location and time; investigate excursions; implement CAPA and verify effectiveness.

Operational controls that sustain sterility

• Cleaning/disinfection: sequenced from clean to dirty, top to bottom; rotate sporicidal agents; honor contact times; document each step.
• Personnel: hand hygiene and garbing verification; media fills and gloved fingertip sampling; retrain after failures or extended absences.
• Facilities: maintain pressure differentials and temperature/humidity; perform smoke studies and HEPA integrity testing per certification schedule.

Design considerations

Evaluate sterile compounding facility design for unidirectional flow, adequate staging, pass-through placement, and materials that resist shedding. Confirm that engineering controls and environmental monitoring together maintain a controlled state.

Documentation and Reporting Procedures

Regulatory compliance documentation

• SOPs with version control, change history, and periodic review.
• Training and competency records for aseptic technique, hazardous drug handling, and emergency response.
• Equipment files: installation, qualification, calibration, certification, and maintenance logs.
• Environmental monitoring data, excursions, investigations, and CAPA.
• Compounding records: formulations, calculations, labels, checks, beyond-use dating rationale, and release decisions.
• Security records: access logs, camera retention, chain-of-custody, discrepancy investigations, and waste reconciliation.

Incident reporting and change control

• Define what to report (near-miss, deviation, excursion, injury, spill, suspected diversion) and how quickly.
• Use structured root-cause analysis and risk re-scoring; link each corrective action to a responsible owner and due date.
• Run change control for new drugs, processes, equipment, layouts, or software—assess impacts on sterility, safety, and security before go-live.

Pharmacy Sterile Compounding Audits

Design a risk-based audit program

• Scope: include personnel practices, environmental performance, documentation, data integrity, chain-of-custody, and engineering controls.
• Cadence: schedule targeted monthly checks, quarterly thematic reviews, and annual full-scope audits; add unannounced spot checks.
• Methods: interviews, direct observation, document review, traceability exercises, and physical inspections of seals, labels, and storage.
• Sampling: prioritize high-risk processes, high-potency APIs, and areas with recent excursions or changes.

Close the loop with metrics and CAPA

• Key metrics: environmental monitoring excursions, aseptic technique failures, access violations, reconciliation discrepancies, and time-to-CAPA closure.
• Effectiveness: verify that actions reduce risk priority numbers and sustain gains; escalate persistent gaps to leadership.

Conclusion

A disciplined Sterile Compounding Pharmacy Security Risk Assessment blends USP 797 sterility expectations with USP 800 containment, robust engineering and administrative controls, vigilant environmental monitoring, airtight documentation, and relentless auditing. When you treat security and quality as one system, you prevent harm, deter diversion, and deliver consistent, inspection-ready performance.

FAQs

What are the key steps in a sterile compounding pharmacy security risk assessment?

Define scope and assets; map workflows; identify threats and failure modes; catalog existing controls; score severity, likelihood, and detectability; prioritize risks; implement engineering, administrative, PPE, and monitoring controls; document actions and owners; and review results after incidents, changes, and audits.

How does USP 797 and 800 compliance affect sterile compounding practices?

USP 797 sets sterility, facility, personnel, and environmental expectations; USP 800 adds hazardous drug handling requirements like containment engineering controls, specialized PPE, and decontamination. For sterile HD work, you must meet both—layer containment and safety onto aseptic process controls and document the rationale for each decision.

What tools are used to conduct an effective risk assessment?

Use standardized Assessment of Risk templates, process maps, failure mode and effects analysis or similar scoring rubrics, environmental monitoring trend reports, access and inventory logs, deviation/incident trackers, and audit checklists. Together they quantify risk, prove control effectiveness, and guide targeted improvements.

How often should sterile compounding security audits be performed?

Run a tiered schedule: targeted monthly spot checks on high-risk areas, quarterly thematic reviews to test broader compliance, and at least one annual full-scope audit. Add unannounced audits after significant changes, excursions, or incidents to confirm sustained control.